Corrigendum to “Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids” [Drug Metabolism and Disposition 54 (2026) 100343]
Drug Metabolism and Disposition · 2026-08 · 54 (8) · 100377
DOI: 10.1016/j.dmd.2026.100377 ↗Kurz gefasst
Korrektur in der Zeitschrift Drug Metabolism and Disposition, 2026-08. Verfasst von Masaki Kumondai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Tohoku University Hospital, Aoba-ku, Sendai, Japan. Electronic address: masaki.kumondai.d5@tohoku.ac.jp.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Aoba-ku, Sendai, Japan. Electronic address: masaki.kumondai.d5@tohoku.ac.jp.
- Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Japan.
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Aoba-ku, Sendai, Japan.
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Aoba-ku, Sendai, Japan; Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Japan.
- Drug Development Research Laboratories, Kyoto R&D Center, Maruho Co, Ltd, Kita-ku, Osaka, Japan.
- Head Office for Open Innovation Business Development Strategy, Tohoku University, Aoba-ku, Sendai, Japan.
Zitieren
APA
Kumondai, M., Yagi, A., Watanabe, M., Lyu, Y., Segawa, R., Sato, M., Tadakuma, R., Inoue, K., Watanabe, H., Takeda, M., Ohshima, Y., Maekawa, M., & Mano, N. (2026). Corrigendum to “Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids” [Drug Metabolism and Disposition 54 (2026) 100343]. Drug Metabolism and Disposition, 54(8), 100377. https://doi.org/10.1016/j.dmd.2026.100377
Vancouver
Kumondai M, Yagi A, Watanabe M, Lyu Y, Segawa R, Sato M, et al. Corrigendum to “Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids” [Drug Metabolism and Disposition 54 (2026) 100343]. Drug Metabolism and Disposition. 2026;54(8):100377. doi:10.1016/j.dmd.2026.100377
BibTeX
@article{Kumondai2026,
author = {Kumondai, Masaki and Yagi, Ayaka and Watanabe, Masahiro and Lyu, Yanlin and Segawa, Ryosuke and Sato, Mayumi and Tadakuma, Ryo and Inoue, Kenji and Watanabe, Hideki and Takeda, Masahiro and Ohshima, Yoshiteru and Maekawa, Masamitsu and Mano, Nariyasu},
title = {Corrigendum to “Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids” [Drug Metabolism and Disposition 54 (2026) 100343]},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {8},
pages = {100377},
doi = {10.1016/j.dmd.2026.100377}
}
EUVIMED